Literature DB >> 8831440

Exaggerated platelet reactivity in major depression.

D L Musselman1, A Tomer, A K Manatunga, B T Knight, M R Porter, S Kasey, U Marzec, L A Harker, C B Nemeroff.   

Abstract

OBJECTIVE: This study investigated whether depressed patients exhibit exaggerated platelet reactivity.
METHOD: In vivo platelet activation, secretion, and dose-response aggregation were measured in 12 depressed patients and eight normal comparison subjects after overnight bed rest and following orthostatic challenge.
RESULTS: The depressed patients exhibited increased platelet activation at baseline, demonstrated by increased binding of monoclonal antibody (moAb) annexin V protein reacting with prothrombinase complex binding sites. Following orthostatic challenge, the depressed patients exhibited increases in binding of moAbs PAC1 and anti-LIBS1 against activated glycoprotein IIb/IIIa and GE12 against P-selectin expressed upon secretion. The normal comparison subjects exhibited increases in platelet activation only with GE12.
CONCLUSIONS: Depressed patients exhibit enhanced baseline platelet activation and responsiveness in comparison with normal subjects. Heightened susceptibility to platelet activation may be a mechanism by which depression is a significant risk factor for ischemic heart and cerebrovascular disease and/or mortality after myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831440     DOI: 10.1176/ajp.153.10.1313

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  86 in total

1.  Interaction between the platelet IIb/IIIa receptor gene and serotonin transporter gene is involved in the formation of the predisposition to myocardial infarction in young men.

Authors:  D V Demidova; O V Sirotkina; S V Kudinov; E I Schwartz
Journal:  Dokl Biochem Biophys       Date:  2002 Nov-Dec       Impact factor: 0.788

Review 2.  Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease?

Authors:  Wei Jiang; Ranga R Krishnan
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

Review 3.  Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma.

Authors:  Gilberto Paz-Filho; Julio Licinio; Ma-Li Wong
Journal:  Braz J Psychiatry       Date:  2010-06       Impact factor: 2.697

4.  Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study.

Authors:  Helen Lavretsky; Ling Zheng; Michael W Weiner; Dan Mungas; Bruce Reed; Joel H Kramer; William Jagust; Helena Chui; Wendy J Mack
Journal:  Am J Psychiatry       Date:  2010-02-16       Impact factor: 18.112

Review 5.  Depression in people with coronary heart disease: prognostic significance and mechanisms.

Authors:  Chris Dickens
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

6.  Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors.

Authors:  Joost P van Melle; Peter de Jonge; Maarten P van den Berg; Harm J Pot; Dirk J van Veldhuisen
Journal:  Drugs       Date:  2006       Impact factor: 9.546

7.  Depression and CHD risk: how should we intervene?

Authors:  Susmita Parashar; Viola Vaccarino
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

8.  Elevation in plasma Abeta42 in geriatric depression: a pilot study.

Authors:  Nunzio Pomara; P Murali Doraiswamy; Lisa M Willoughby; Amy E Roth; Benoit H Mulsant; John J Sidtis; Pankaj D Mehta; Charles F Reynolds; Bruce G Pollock
Journal:  Neurochem Res       Date:  2006-04-01       Impact factor: 3.996

Review 9.  Heart and mind: (1) relationship between cardiovascular and psychiatric conditions.

Authors:  S U Shah; A White; S White; W A Littler
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

10.  Depression and whole blood serotonin in patients with coronary heart disease from the Heart and Soul Study.

Authors:  Lawson R Wulsin; Dominique Musselman; Christian Otte; Erica Bruce; Sadia Ali; Mary A Whooley
Journal:  Psychosom Med       Date:  2009-03-17       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.